These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8567880)

  • 1. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients.
    Ollert MW; Wende C; Görlich M; McMullan-Vogel CG; Borg-von Zepelin M; Vogel CW; Korting HC
    J Clin Microbiol; 1995 Oct; 33(10):2543-9. PubMed ID: 8567880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of virulence attributes in oral Candida albicans isolates from human immunodeficiency virus-positive individuals.
    Mane A; Gaikwad S; Bembalkar S; Risbud A
    J Med Microbiol; 2012 Feb; 61(Pt 2):285-290. PubMed ID: 21959206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype distribution and secretory acid proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis.
    McMullan-Vogel CG; Jüde HD; Ollert MW; Vogel CW
    Oral Microbiol Immunol; 1999 Jun; 14(3):183-9. PubMed ID: 10495713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects.
    De Bernardis F; Boccanera M; Rainaldi L; Guerra CE; Quinti I; Cassone A
    Eur J Epidemiol; 1992 May; 8(3):362-7. PubMed ID: 1356827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.
    Tavanti A; Pardini G; Campa D; Davini P; Lupetti A; Senesi S
    J Clin Microbiol; 2004 Oct; 42(10):4726-34. PubMed ID: 15472333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents.
    Wu T; Samaranayake LP; Cao BY; Wang J
    J Med Microbiol; 1996 Apr; 44(4):311-6. PubMed ID: 8606360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
    Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
    J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection.
    Anil S; Ellepola AN; Samaranayake LP
    Mycopathologia; 2002; 153(4):179-85. PubMed ID: 12014477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
    Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis.
    Tamai IA; Pakbin B; Fasaei BN
    BMC Res Notes; 2021 Mar; 14(1):93. PubMed ID: 33691787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Perea S; López-Ribot JL; Wickes BL; Kirkpatrick WR; Dib OP; Bachmann SP; Keller SM; Martinez M; Patterson TF
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1695-703. PubMed ID: 12019078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
    Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
    Pathol Biol (Paris); 1994 Jun; 42(6):567-73. PubMed ID: 7854856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence of different Candida dubliniensis isolates in the presence of fluconazole.
    Borg-von Zepelin M; Niederhaus T; Gross U; Seibold M; Monod M; Tintelnot K
    AIDS; 2002 Jun; 16(9):1237-44. PubMed ID: 12045488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.